FR2347M - Médicament a base de sulfanilamides. - Google Patents

Médicament a base de sulfanilamides.

Info

Publication number
FR2347M
FR2347M FR922955A FR922955A FR2347M FR 2347 M FR2347 M FR 2347M FR 922955 A FR922955 A FR 922955A FR 922955 A FR922955 A FR 922955A FR 2347 M FR2347 M FR 2347M
Authority
FR
France
Prior art keywords
sulfanilamides
product based
medicinal product
medicinal
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR922955A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
JR Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR913848A external-priority patent/FR1339747A/fr
Application filed by JR Geigy AG filed Critical JR Geigy AG
Priority to FR922955A priority Critical patent/FR2347M/fr
Application granted granted Critical
Publication of FR2347M publication Critical patent/FR2347M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
FR922955A 1961-10-31 1963-01-29 Médicament a base de sulfanilamides. Active FR2347M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR922955A FR2347M (fr) 1961-10-31 1963-01-29 Médicament a base de sulfanilamides.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1258861 1961-10-31
FR913848A FR1339747A (fr) 1961-10-31 1962-10-30 Nouveaux dérivés du sulfanilamide et leur préparation
FR922955A FR2347M (fr) 1961-10-31 1963-01-29 Médicament a base de sulfanilamides.

Publications (1)

Publication Number Publication Date
FR2347M true FR2347M (fr) 1964-02-17

Family

ID=4384453

Family Applications (1)

Application Number Title Priority Date Filing Date
FR922955A Active FR2347M (fr) 1961-10-31 1963-01-29 Médicament a base de sulfanilamides.

Country Status (6)

Country Link
US (1) US3308119A (fr)
BE (1) BE624360A (fr)
ES (2) ES281966A1 (fr)
FR (1) FR2347M (fr)
GB (2) GB995895A (fr)
NL (1) NL284876A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3525977A1 (de) * 1985-07-20 1987-01-29 Bayer Ag Verfahren zur herstellung von 2-cyanamino-pyrimidin-derivaten

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2494524A (en) * 1943-01-12 1950-01-10 Sharp & Dohme Inc 2-(benzene sulfonamido)-tetra-hydrobenzothiazoles

Also Published As

Publication number Publication date
BE624360A (fr)
GB995896A (en) 1965-06-23
ES281966A1 (es) 1963-04-01
US3308119A (en) 1967-03-07
ES282004A1 (es) 1963-05-01
GB995895A (en) 1965-06-23
NL284876A (fr)

Similar Documents

Publication Publication Date Title
FR1538M (fr) Médicaments a base de pipérazine.
FR1275M (fr) Médicament a base de colibacilles vivants.
FR1711M (fr) Médicament a base de nouveaux éthers.
FR2094M (fr) Médicament a base d'un nouvel hendécapeptide.
FR1891M (fr) Médicament a base d'un phénoxy-alcane.
FR1827M (fr) Médicament a base de 1.5-benzo-dioxépannes.
FR2127M (fr) Médicament a base de dérivé du thiaxanthene.
FR2410M (fr) Médicament a base de dérivé de l'oxazine.
FR2231M (fr) Médicament a base de nouvelles dibenzothiéphinnes.
FR2347M (fr) Médicament a base de sulfanilamides.
FR1075M (fr) Médicament a base de 4-nitro-3-hydroxy-thiofene-2-carboxylate de méthyle.
FR1504M (fr) Médicament a base de dérivé du thiaxanthene.
FR2093M (fr) Médicament a base de dérivé d'hydroxy-dibenzocycloheptane.
FR2577M (fr) Médicament a base de naphtyl-amino-imidazoline.
FR1214M (fr) Médicament a base de β-camphosulfonate de n-méthyl-éphédrine.
FR1144M (fr) Médicament a base de 1.2-diaryl-3.5-dioxo-pyrazolidines.
FR1947M (fr) Médicament a base de dérivé de thiéno-benzothiopyranne.
FR2161M (fr) Médicament a base de dérivé d'hydrazine.
FR1864M (fr) Médicament nouveau a base de mercapto-acyl-amido-5-nitrothiazoles.
FR1824M (fr) Médicament a base d'amines tertiaires.
FR3757M (fr) Médicament a base de streptokinase.
FR2180M (fr) Médicament a base de nouveaux 10-alcényl-stéroides.
FR1802M (fr) Médicament a base de nouveaux naphtaquinols.
FR1087M (fr) Médicament a base de sulfonylurée.
FR1725M (fr) Médicament a base de dérivés de pipéazine.